药市场,(给药途径[Oral Drug Delivery, Skin Drug Delivery, Ophthalmic Drug Delivery, Rectal Drug Delivery, Vaginal Drug Delivery, Nasal Drug Delivery], by Product Type [Device (Transdermal gel, Transdermal Patches); Formulation (Solid Topical Formulations, Liquid Topical Formulation, Semi-Solid Topical Formulations); by End Use (Hospitals, Private Clinics, Homecare setting, Pharmacy Stores, Others)]; and Geography - Trend, Analysis and Forecast till 2025

公布日期：2018年6月
页数：0
格式：PDF.
报告ID：PM1328
基准年：
历史数据：

报告摘要

全球药物交付市场规模主要受到用于药物递送的技术先进产品的需求日益增加，以及越来越多的老年人群体中慢性疾病的数量增加。

药物递送通过注射或各种其他装置称为人体中的药物施用。药物递送装置用于在各种途径的帮助下在身体中注射治疗物质。这些给药途径取决于患者患有患者的疾病，以及可用的药物的性质。药物通过适当诊断疾病，有助于改善和延长生命。最近，药物递送包括目标交付，专注于身体的目标区域。为了实现效率，目标药物有效地作用，而不为其他身体部位产生任何副作用。

Drug delivery devices also play an important role as they are conventional and implantable. The devices not only help the efficiency but also enhance the accuracy for drug delivery. For instance, the device can help in accurately administrating the drugs like insulin, the devices used are infusion catheters namely valves, set, needles, cannulas and many more. Transcellular and paracellular are most commonly used routes for drug administration. The practice for drug delivery has changed in past few decades that is creating a good pace for the new and existing manufacturers in the near future.

Rising number of technologically advanced products that are used for drug delivery and rising number of chronic diseases globally to boost the drug delivery market.

The drug delivery market is basically driven by the rising prevalence of chronic disease, and increased number of clinical trials that focus on the biologics drugs in the market. Similarly, the rising technological advancements and continuous new product development would also influence the market growth. Moreover, increased government focus on improving the efficiency and safety of drugs will drive the market significantly in the coming years.

越来越多的人口，皮肤过敏的风险上升是推动药物交付市场的关键因素。另一方面，对有效和高效的药物递送系统的需求增加和糖尿病患者的上升数量在预测期间也会积极影响药物输送市场。

然而，一些监管框架问题和市场批准的监管框架问题和市场上可用的药物的批准是妨碍药物交付市场的因素。

Global Drug Delivery Market Taxonomy

全球药物交付市场规模在行政，产品，最终用途和地理领域进行了分割。

在管理途径的基础上，全球药物交付市场规模被分割为：

Oral Drug Delivery
皮肤药物递送
眼科药物递送
直肠药物递送
阴道药物递送
Nasal Drug Delivery

在产品开发的基础上，全球药物交付市场份额被分割为：

设备
透皮凝胶
Transdermal Patches
公式
固体局部配方
液体局部配方
半固体局部配方

On the basis of end use, the global drug delivery market size is segmented as:

医院
私人诊所
家庭护理环境
药房商店
Others

地理上，药物交付市场分为北美，欧洲，亚太地区，拉丁美洲和中东和非洲。

糖尿病组合药物的技术进步与创新，有利的报销政策，以引领北美全球药物交付市场份额。

On the basis of geography, North America is expected to dominate the global drug delivery market over forecast period. Rising prevalence of diabetes and other life style disorders is the major factor driving the market. Furthermore, rising awareness for the use of targeted drug delivery, and increasing government expenditure towards research & development of new drugs, and presence of major key players in this region would also influence the drug delivery market in North America.

然而，亚太市场估计在预测期间迅速增长。患糖尿病群数量越来越多，经济成本的治疗药物的可用性以及增加该地区的可支配收入是预计在即将到来的几年期间旨在管理药物送货市场的主要因素。